Stay updated with breaking news from Kumar visvanathan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Australian biotech, EnGeneIC, develops world-first nanocellular anti-COVID-19 vaccine that defeats mutant viruses and stimulates a broad anti-viral response forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Gilead Sciences • Five diverse research projects spanning COVID-19, HIV, hepatitis C elimination, CAR T cell therapy and fungal infections are the 2021 recipients of the Gilead Fellowship Research Grant. • Now in its 11th year, the Fellowship has granted more than $2.6 million to research projects throughout Australia which often struggle to secure funding or face high competition. Melbourne, 29 June 2021 – Gilead Sciences Australia today announced the five recipients of the 2021 Gilead Fellowship Research Grants Program one of which will investigate the medium- and long-term impacts of COVID-19 on patients’ health and wellbeing. Grant recipient Professor Kumar Visvanathan, Infectious Diseases Physician, Academic Lead of Medicine at the University of Melbourne campus and Co-Director of the Immunology Research Centre at St Vincent’s Hospital, Melbourne will follow almost 100 individuals with confirmed COVID-19 infection over a six month period to look at C ....